BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC) Sep 19, 2024 11:45AM
BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC) Sep 9, 2024 08:28AM
BMO Capital Reiterates Outperform Rating on C4 Therapeutics (CCCC) Aug 20, 2024 07:45AM
C4 Therapeutics (CCCC) PT Lowered to $20 at BMO Capital Apr 11, 2022 07:00AM
C4 Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares Jun 21, 2021 04:01PM


Jun 21, 2021 04:01PM C4 Therapeutics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Jun 21, 2021 01:07PM C4 Therapeutics (CCCC) PT Lowered to $53 at BMO Capital, Keeps 'Outperform'
Jun 17, 2021 06:08AM C4 Therapeutics Inc. (CCCC) Prices 4.25M Share Public Offering at $37/sh
Jun 16, 2021 07:51PM C4 Therapeutics Announces Pricing of Public Offering
Jun 16, 2021 07:51PM C4 Therapeutics Announces Pricing of Public Offering
Jun 14, 2021 04:13PM C4 Therapeutics Inc. (CCCC) Announces Proposed Offering of 4.25M Shares
Jun 14, 2021 04:12PM C4 Therapeutics Launches Proposed Public Offering
Jun 14, 2021 04:12PM C4 Therapeutics Launches Proposed Public Offering
Mar 31, 2021 01:40AM BMO Capital Starts C4 Therapeutics (CCCC) at Outperform
Oct 27, 2020 04:33AM BMO Capital Starts C4 Therapeutics (CCCC) at Outperform
Oct 6, 2020 04:05PM C4 Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Oct 6, 2020 04:05PM C4 Therapeutics Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Oct 2, 2020 11:38AM C4 Therapeutics (CCCC) IPO Opens 40% Higher
Oct 2, 2020 06:07AM C4 Therapeutics Inc. (CCCC) Prices 9.6M Share Upsized IPO at $19/Sh
Oct 1, 2020 09:58PM C4 Therapeutics Announces Pricing of an Upsized Initial Public Offering
Oct 1, 2020 09:58PM C4 Therapeutics Announces Pricing of an Upsized Initial Public Offering